Seattle Genetics reported $108.12M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Agios Pharmaceuticals AGIO:US USD 517K 82K
Amgen AMGN:US USD 1.59B 78M
Astellas Pharma 4503:JP JPY 62.78B 26.09B
Bayer BAYN:GR EUR 4.25B 1.43B
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Clovis Oncology CLVS:US USD 8.61M 607K
Daiichi Sankyo 4568:JP JPY 84.77B 9.97B
Eisai 4523:JP JPY 45.13B 2.27B
Eli Lilly And LLY:US USD 1.58B 148.6M
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Exelixis EXEL:US USD 15.3M 1.82M
Gilead Sciences GILD:US USD 1.4B 47M
Glaxosmithkline GSK:US GBP 2.39B 250M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Insmed INSM:US USD 13.47M 2.92M
Karyopharm Therapeutics KPTI:US USD 980K 41K
MacroGenics MGNX:US USD 3.14M 741K
Merk MRK:US USD 3.43B 715M
Moderna Inc MRNA:US USD 1.1B 281M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Novartis NOVN:VX USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Seattle Genetics SGEN:US USD 108.12M 2.02M
Takeda 4502:JP JPY 305.44B 12.56B
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
YTE INCY:US USD 49.28M 4.05M